ResearcherNebraska Medical CenterActive in the last 2 years
Ayoola O. Ogunleye
Matched on ORCID iD 0000-0001-8533-4875; OpenAlex author ID A5052826861. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2022: 1 paper · 2023: 1 paper · 2024: 2 papers
Papers 4
- Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LAMA5/ITGA4 Axis. Co-author DOI 10.1053/j.gastro.2023.12.018↗
- PAF1/HIF1α axis rewires the glycolytic metabolism to fuel aggressiveness of pancreatic cancer. Co-author DOI 10.1186/s40170-024-00354-2↗
- Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression. Co-author DOI 10.1093/stmcls/sxad017↗
- PAF1 cooperates with YAP1 in metaplastic ducts to promote pancreatic cancer. First author DOI 10.1038/s41419-022-05258-x↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rama Krishna Nimmakayala · 4 shared papers, 2022–2024 · strength 0.80
- Paper Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression. DOI 10.1093/stmcls/sxad017↗
- Paper PAF1/HIF1α axis rewires the glycolytic metabolism to fuel aggressiveness of pancreatic cancer. DOI 10.1186/s40170-024-00354-2↗
- Paper Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LA… DOI 10.1053/j.gastro.2023.12.018↗
- Surinder K. Batra · 4 shared papers, 2022–2024 · strength 0.80
- Paper Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression. DOI 10.1093/stmcls/sxad017↗
- Paper PAF1/HIF1α axis rewires the glycolytic metabolism to fuel aggressiveness of pancreatic cancer. DOI 10.1186/s40170-024-00354-2↗
- Paper Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LA… DOI 10.1053/j.gastro.2023.12.018↗
- Moorthy Palanimuthu Ponnusamy · 4 shared papers, 2022–2024 · strength 0.80
- Paper Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression. DOI 10.1093/stmcls/sxad017↗
- Paper PAF1/HIF1α axis rewires the glycolytic metabolism to fuel aggressiveness of pancreatic cancer. DOI 10.1186/s40170-024-00354-2↗
- Paper Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LA… DOI 10.1053/j.gastro.2023.12.018↗
- Sanchita Rauth · 3 shared papers, 2022–2024 · strength 0.53
- Paper PAF1/HIF1α axis rewires the glycolytic metabolism to fuel aggressiveness of pancreatic cancer. DOI 10.1186/s40170-024-00354-2↗
- Paper Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LA… DOI 10.1053/j.gastro.2023.12.018↗
- Paper PAF1 cooperates with YAP1 in metaplastic ducts to promote pancreatic cancer. DOI 10.1038/s41419-022-05258-x↗
- Jesse L. Cox · 3 shared papers, 2022–2024 · strength 0.53
- Paper PAF1/HIF1α axis rewires the glycolytic metabolism to fuel aggressiveness of pancreatic cancer. DOI 10.1186/s40170-024-00354-2↗
- Paper Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LA… DOI 10.1053/j.gastro.2023.12.018↗
- Paper PAF1 cooperates with YAP1 in metaplastic ducts to promote pancreatic cancer. DOI 10.1038/s41419-022-05258-x↗
- Zahraa Wajih Alsafwani · 2 shared papers, 2024 · strength 0.39
- Palanisamy Nallasamy · 2 shared papers, 2022–2024 · strength 0.31
- Seema C. Parte · 2 shared papers, 2022–2024 · strength 0.31
- Subodh M. Lele · 2 shared papers, 2022–2024 · strength 0.31
- Saravanakumar Marimuthu · 1 shared paper, 2024 · strength 0.22
- Frank Leon · 1 shared paper, 2024 · strength 0.18
- Shailender Singh · 1 shared paper, 2024 · strength 0.18
- Venkatesh Varadharaj · 1 shared paper, 2022 · strength 0.14
- Nivedeta Krishna Kumar · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.